- Home
- PUMP vs MDXG Comparison
PUMP vs MDXG Comparison
Compare PUMP & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- MDXG
- Stock Information
- Founded
- PUMP 2007
- MDXG 2006
- Country
- PUMP United States
- MDXG United States
- Employees
- PUMP N/A
- MDXG N/A
- Industry
- PUMP Oilfield Services/Equipment
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- PUMP Energy
- MDXG Health Care
- Exchange
- PUMP Nasdaq
- MDXG Nasdaq
- Market Cap
- PUMP 938.7M
- MDXG 1.1B
- IPO Year
- PUMP 2017
- MDXG N/A
- Fundamental
- Price
- PUMP $8.91
- MDXG $9.22
- Analyst Decision
- PUMP Buy
- MDXG Strong Buy
- Analyst Count
- PUMP 7
- MDXG 5
- Target Price
- PUMP $10.83
- MDXG $12.00
- AVG Volume (30 Days)
- PUMP 1.7M
- MDXG 774.5K
- Earning Date
- PUMP 10-30-2024
- MDXG 10-30-2024
- Dividend Yield
- PUMP N/A
- MDXG N/A
- EPS Growth
- PUMP N/A
- MDXG N/A
- EPS
- PUMP N/A
- MDXG 0.52
- Revenue
- PUMP $1,471,508,000.00
- MDXG $342,804,000.00
- Revenue This Year
- PUMP N/A
- MDXG $9.56
- Revenue Next Year
- PUMP N/A
- MDXG $9.19
- P/E Ratio
- PUMP N/A
- MDXG $17.61
- Revenue Growth
- PUMP N/A
- MDXG 10.93
- 52 Week Low
- PUMP $6.54
- MDXG $5.47
- 52 Week High
- PUMP $10.02
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- PUMP 55.22
- MDXG 62.95
- Support Level
- PUMP $7.69
- MDXG $9.07
- Resistance Level
- PUMP $9.73
- MDXG $10.14
- Average True Range (ATR)
- PUMP 0.51
- MDXG 0.31
- MACD
- PUMP 0.05
- MDXG -0.11
- Stochastic Oscillator
- PUMP 59.90
- MDXG 41.67
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and coiled tubing.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.